Date closed: 12/12/2019
Value: US$191.7 million
On December 12, 2019, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
(TSX:AUP) (Aurinia or the Company) announced the closing of its
previously announced underwritten public offering of 12,782,439
common shares, including 1,667,274 common shares pursuant to the
full exercise of the underwriters' option to purchase
additional common shares (the Offering). The shares were sold at a
public offering price of US$15.00 per share. The gross offering
proceeds to the Company from this Offering are approximately
US$191.7 million, before deducting underwriting discounts and
commissions and other estimated offering expenses.
Jefferies LLC and SVB Leerink LLC acted as joint book-running
managers for the Offering. H.C. Wainwright & Co. LLC,
Oppenheimer & Co. Inc., and Bloom Burton Securities Inc. acted
as co-managers for the Offering.